Skip to content
StockMarketAgent
Direct answer
BRK.B trades against a final fair-value range of $374.65-$742.60, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs. Fair value range: low $375, high $743, with mid-point at $550.
Stock analysis

BRK.B Berkshire Hathaway Inc. Class B fair value $550–$743

BRK.B
By StockMarketAgent.AI team· supervised by
Analisado: 2026-05-08Próxima atualização: 2026-08-08Methodology v2.4Archetype: FinancialNYSE · Financials
View archive
Preço
$475.08
▲ +74.67 (+15.72%)
Valor justo
$550
$550–$743
Classificação
Comprar
confidence 65/100
Potencial de alta
+15.7%
upside to fair value
Margem de segurança
$467.29
buy below · 15%
Capitalização de mercado
$1.02T
P/E fwd 22.4
Fonte em inglêsPT
Exibindo a fonte em inglês enquanto traduzimos
Este relatório ainda não foi traduzido. Atualize em alguns minutos assim que a fila de tradução recuperar o atraso.

§1 Resumo executivo

  • Composite fair value $550 with high case $743.
  • Implied upside of 15.7% to fair value.
  • Moat 9/10 · confidence 65/100 · Financial.
  • Trades at a measured discount to fair value with adequate margin of safety.
Fair value
$550
Margin of safety
+13.6%
Confidence
65/100
Moat
9/10

Educational analysis only — not financial advice. Always do your own due diligence.

$475.08Price
FV $549.75
High $742.6

BRK.B trades against a final fair-value range of $374.65-$742.60, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs.

  • Zero-cost insurance float (~$170B+) functions
    Zero-cost insurance float (~$170B+) functions as permanent, non-callable leverage — no competitor replicates this at scale
  • BNSF and BHE operate as
    BNSF and BHE operate as regulated/quasi-monopoly infrastructure with pricing power indexed to inflation
  • Cycle upside
    Hard insurance market extends through 2027, driving premium growth of 8-12% and combined ratios below 95%. Rising interest rates boost float income. BHE rate cases approved, improving utility ROE toward allowed returns.

§2 Cenário pessimista

Under a combined stress scenario — recession reducing underwriting profits by 40%, equity portfolio declining 30%, and BNSF volumes falling 15% — operating earnings could compress to ~$25B from ~$40B normalized. At 10x stressed earnings plus $300B cash at par, trough equity value approximates $400/share (0.95x book). The cash fortress prevents permanent impairment but does not prevent a 15-20% drawdown.

Como esta tese pode falhar

Succession-driven capital allocation deterioration

25-35% over 5 years· Medium

Greg Abel lacks Buffett's investment track record. A single large misallocation ($50B+ acquisition at inflated multiples) could permanently impair book value growth trajectory and trigger conglomerate discount widening from 1.4x to sub-1.0x P/B.

FV impact
−30% to −40% ($290-$330/share)
Trigger
2026-2030

PacifiCorp wildfire liability crystallization

15-20%· Low

BHE subsidiary PacifiCorp faces multi-billion dollar wildfire claims in Oregon. If total liabilities exceed $15B (vs current reserves), BHE equity could be impaired, requiring Berkshire parent capital injection and reducing consolidated book value.

FV impact
−8% to −12% ($420-$450/share)
Trigger
2026-2028

Forced Apple divestiture or mark-to-market tax event

10-15%· Low

Regulatory or tax-policy changes force liquidation of the ~$70B Apple position, crystallizing $50B+ in embedded capital gains taxes and permanently reducing the equity portfolio's compounding capacity.

FV impact
−10% to −15% ($400-$430/share)
Trigger
2027-2030
Sinais de alerta antecipado para monitorar
MétricaAtualLimite de gatilho
Combined ratio sustained above 100% for two consecutive quartersMonitorDeterioration versus the report thesis
Book value per share growth decelerating below 5% annualizedMonitorDeterioration versus the report thesis
Cash deployment into acquisitions above 2x trailing book value of targetMonitorDeterioration versus the report thesis
BNSF operating ratio exceeding 70% (currently ~60%)MonitorDeterioration versus the report thesis
Greg Abel increasing centralization or departing from decentralized operating philosophyMonitorDeterioration versus the report thesis

§3 Histórico financeiro

Demonstração de resultados — últimos seis períodos
ItemT−0T−1T−2T−3T−4CAGR
Período2021-12-312022-12-312023-12-312024-12-312025-12-31Trend
Receita$276.19B$302.02B$364.48B$371.43B$371.44B+7.7%
Lucro bruto
Lucro operacional
Lucro líquido$89.94B$-22.76B$96.22B$89.00B$66.97B-7.1%
LPA (diluído)
EBITDA
P&D
SG&A

Pontuações de qualidade

Piotroski F-score
2 / 9
Composto de qualidade 0–9
OCF / Lucro líquido
0.69×
>1 indica alta qualidade dos lucros
Limite de qualidade contábil
Fail
Limite ajustado ao setor
ROIC
Retorno sobre o capital investido
Seção 3

Numbers analysis

Fluxo de caixa

Cash-flow quality is reflected in the OCF / net income, accounting-quality, and ROIC rows above.

Alocação de capital

Capital allocation should be evaluated against reinvestment needs, balance-sheet strength, and shareholder returns.

Assinantes individuais — a partir do §411 seções a mais

Leia a análise completa — 11 seções a mais.

Competitive moat, industry cycle, peer comparison, intrinsic valuation, sensitivity, scenarios, earnings decision tree, position management, investor perspectives, scorecard, and final recommendation.

Relatório completo para cada ticker coberto
24 meses de arquivo de classificações
Briefings da lista de acompanhamento + alertas de mudança de classificação
Exportação PDF + DOCX em qualquer idioma
Iniciar teste grátis
Cancele a qualquer momento.
FAQ

BRK.B — frequently asked questions

  1. Based on our latest independent analysis, BRK.B looks meaningfully undervalued. The current price is $475 versus a composite fair-value midpoint of $550 (range $375–$743), which implies roughly 15.7% upside to the midpoint.